Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia

被引：60

作者：

Fisher, MM

Merefield, D

Baldo, B

机构：

[1] Univ Sydney, Dept Anaesthesia, Sydney, NSW 2006, Australia

[2] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia

[3] Royal N Shore Hosp, Intens Therapy Unit, Sydney, NSW, Australia

[4] Mater Misericordiae Hosp, Bundaberg, Qld, Australia

[5] Royal N Shore Hosp, Kolling Inst Med Res, Mol Immunol Unit, Sydney, NSW, Australia

来源：

BRITISH JOURNAL OF ANAESTHESIA | 1999年 / 82卷 / 05期

关键词：

complications; anaphylaxis; neuromuscular block; allergy;

D O I：

10.1093/bja/82.5.770

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Skin testing is used widely to determine the drug responsible for an anaphylactic reaction during anaesthesia. When a neuromuscular blocking drug is incriminated as the cause of a reaction, it is usual for neuromuscular blocking drugs which do not produce positive skin tests to be considered safe for subsequent use during anaesthesia. We describe three patients in whom false negative skin tests led to a second severe anaphylactic reaction to another neuromuscular blocking drug.

引用

页码：770 / 773

页数：4

共 16 条

[1] ANAPHYLAXIS TO MUSCLE-RELAXANT DRUGS - CROSS-REACTIVITY AND MOLECULAR-BASIS OF BINDING OF IGE-ANTIBODIES DETECTED BY RADIOIMMUNOASSAY [J].

BALDO, BA ;

FISHER, MM .

MOLECULAR IMMUNOLOGY, 1983, 20 (12) :1393-1400

[2] SUBSTITUTED AMMONIUM-IONS AS ALLERGENIC DETERMINANTS IN DRUG ALLERGY [J].

BALDO, BA ;

FISHER, MM .

NATURE, 1983, 306 (5940) :262-264

[3] DETECTION OF SERUM IGE ANTIBODIES THAT REACT WITH ALCURONIUM AND TUBOCURARINE AFTER LIFE-THREATENING REACTIONS TO MUSCLE-RELAXANT DRUGS [J].

BALDO, BA ;

FISHER, MM .

ANAESTHESIA AND INTENSIVE CARE, 1983, 11 (03) :194-197

[4]

Bouaziz H, 1998, Curr Opin Anaesthesiol, V11, P339, DOI 10.1097/00001503-199806000-00018

[5]

FISHER M, 1994, EUR J ANAESTH, V11, P263

[6] ANAPHYLAXIS TO MUSCLE-RELAXANTS - CROSS SENSITIVITY BETWEEN RELAXANTS [J].

FISHER, MM .

ANAESTHESIA AND INTENSIVE CARE, 1980, 8 (02) :211-213

[7]

FISHER MM, 1983, ANESTH ANALG, V62, P559

[8] Mast cell tryptase in anaesthetic anaphylactoid reactions [J].

Fisher, MM ;

Baldo, BA .

BRITISH JOURNAL OF ANAESTHESIA, 1998, 80 (01) :26-29

[9] Agents causing anaphylactic shocks during anaesthesia. Third French multicentric survey (1992-1994) [J].

Laxenaire, MC ;

Cottineau, C ;

Neidhardt, M ;

deLara, MT ;

Rakotoseheno, JC ;

Bricard, H ;

Vergnaud, MC ;

Laroche, D ;

Dubois, F ;

Jacson, F ;

ClaussnerPoulignan, M ;

Jacquot, C ;

Zambelli, P ;

Hautier, MB ;

Facon, A ;

Orsel, I ;

Motin, J ;

Dubost, R ;

Courvoisier, L ;

Birnbaum, J ;

Vervloet, D ;

BonnetBoyer, MC ;

Occelli, G ;

Amedeo, J ;

Mouton, C ;

MoneretVautrin, DA ;

Widmer, S ;

Gueant, JL ;

Joncourt, M ;

BrunetLangot, D ;

Korinek, AM ;

Leynadier, F ;

Breuil, K ;

Robert, A ;

Dzviga, C ;

Hammann, M ;

Valfrey, J ;

Didier, A .

ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1996, 15 (08) :1211-1218

[10] PREDICTIVE VALUE OF INTRADERMAL TESTS WITH MUSCLE-RELAXANTS [J].

LEYNADIER, F ;

CALINAUX, C ;

DRY, J .

ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1989, 8 (02) :98-101

← 1 2 →